Eterna Therapeutics Inc (ERNA) Financials

$4.17

$0.15 (3.61%)

As on 11-Sep-2026 16:00EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	0.58	0.07	--	--
Cost of Revenue	0.16	0.26	0.10	0.24	0.50	0.46
Gross Profit	-0.16	-0.26	0.49	-0.17	-0.50	-0.46
Operating Expenses	11.65	9.32	16.16	20.97	33.22	113.73
Operating Profit (EBIT)	-11.74	-9.32	-15.67	-21.14	-33.22	-113.73
Other Income	--	--	--	--	--	--
Profit before Tax	-12.35	-14.13	-44.51	-21.67	-24.53	-122.48
Provision for Tax	-0.09	-0.05	0.03	0.00	0.05	0.06
Profit after Tax (Net Income)	-12.26	-14.08	-44.54	-21.67	-24.58	-122.55
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-24.60	-122.56

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	3.20	2.40	1.70	2.23	12.11	25.50
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.18	0.32	0.63	40.33	2.52	2.34
Current Liabilities	2.93	3.11	2.94	6.57	7.65	3.68
Total Liabilities	9.25	5.83	5.27	49.13	22.28	31.53

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.42	2.70	2.92	39.53	8.60	12.76
Current Assets	5.89	3.13	2.35	9.60	13.68	18.77
Total Assets	9.25	5.83	5.27	49.13	22.28	31.53
Total Debt*	0.35	0.49	0.68	41.84	4.14	2.72
Net Current Assets	2.96	0.02	-0.59	3.03	6.03	15.09

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-7.02	-15.84	-20.41	-20.98	-23.49
Cash Flow from Investing Activities	--	-0.04	-0.37	-0.02	-0.05	-22.74
Cash from Financing Activities	--	7.21	6.26	16.56	19.58	61.59
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-15.27	-44.82	-13.00	-60.07	-83.77	-706.31
Cash EPS ($)	--	-43.99	-12.52	-58.05	-82.08	-703.67
Adjusted Book Value ($)	--	7.64	0.50	6.19	41.26	147.00
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-22.33	-4.62	-56.58	-71.49	-135.38
Free Cash Flow per Share ($)	--	-22.45	-4.73	-56.63	-72.51	-136.27

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-533.89	-191.73	-71.84	-110.54	-631.94
ROE (%)	-437.67	-686.69	-2,264.31	-302.20	-130.70	-739.05
ROA (%)	-125.83	-253.70	-163.74	-60.69	-91.36	-551.62
EBIT Margin (%)	--	--	-6,487.46	-30,966.18	--	--
Net Margin (%)	--	--	-7,652.75	-31,864.71	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-1.00	7.56	--	--	-1.00
EBIT Growth (%)	64.61	62.65	-79.31	14.07	79.98	-362.12
Net Profit Growth (%)	71.95	68.38	-105.55	11.84	79.94	-1,129.27
EPS Growth (%)	80.51	-2.45	0.78	0.28	0.88	-6.50
Book Value Growth (%)	215.24	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.03	-0.02	-0.03	-0.04	-0.01
Price / Book Value	1.65	0.16	0.59	0.29	0.08	0.03
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.29	0.07	0.00	-1.75	0.27	0.11
Close Price ($)	6.65	30.00	110.25	675.00	1,207.50	1,563.75
High Price ($)	96.19	360.00	984.38	2,005.80	2,681.25	30,251.25
Low Price ($)	3.18	27.00	83.36	315.00	63.71	832.50
Market Cap ($ Cr)	5.03	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.20	0.40	18.74	0.34	0.11
Short term debt to equity ratio	0.05	0.09	0.12	0.99	0.17	0.02
Current Ratio	2.01	1.01	0.80	1.46	1.79	5.10
Quick Ratio	2.01	--	--	--	1.91	--
Interest Coverage	-142.64	-522.30	-5.59	-34.29	-816.80	-1,654.15

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	75.09	625.00	--	--
Asset Turnover	--	--	0.02	0.00	--	--
Receivable days	--	--	270.49	3,695.47	--	--
Inventory Days	--	--	--	-1,471.83	-698.90	-92.31
Payable days	--	1,976.24	5,303.73	2,079.29	1,240.16	1,205.56
Cash Conversion Cycle	--	--	--	144.34	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.